Pipeline Report Shows Good Prospects for People with HIV, HCV, and TB
- Details
- Category: Experimental HIV Drugs
- Published on Friday, 29 July 2011 00:00
- Written by TAG & iBase
An updated summary of experimental therapies for HIV, hepatitis C virus (HCV), and tuberculosis, produced by treatment advocates with i-Base and TAG, shows rapid progress in therapies for HCV and steady progress in the area of HIV.
Simpler TB Therapy Prevents Active Disease in HIV+ People
- Details
- Category: Tuberculosis (TB)
- Published on Sunday, 17 July 2011 00:00
- Written by Liz Highleyman
A combination regimen taken once-weekly for 3 months works as well as a single drug taken daily for 6 months at preventing development of full-blown tuberculosis (TB) disease among HIV positive adults infected with tuberculosis bacteria. 
Shorter Treatment More Effective for Latent TB
- Details
- Category: Tuberculosis (TB)
- Published on Friday, 20 May 2011 05:50
- Written by Liz Highleyman
Rifapentine plus isoniazid administered once-weekly for 3 months to treat latent tuberculosis worked better than daily isoniazid for 9 months, with fewer premature treatment discontinuations, researchers reported at the recent American Thoracic Society meeting.
Updated CDC HIV and TB Fact Sheet
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 28 June 2011 12:30
- Written by HIVandHepatitis.com
The Centers for Disease Control and Prevention (CDC) has issued a revised fact sheet on tuberculosis in people with HIV.
TB Fixed-dose Coformulation Works as Well as Separate Drugs
- Details
- Category: Tuberculosis (TB)
- Published on Friday, 15 April 2011 06:57
- Written by Liz Highleyman
A 4-drug combination containing rifampicin, isoniazid, pyrazinamide, and ethambutol treats pulmonary tuberculosis (TB) as effectively as individual medications.
Web Design and Development by